ACON · NASDAQ
Aclarion (ACON) Stock Price & Fundamentals
Aclarion (ACON) closed at $551.07 on Oct 9, 2026, down 0.24% from the previous close of $552.39.
Share price, past year
1Y −5.62%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $551.07 |
| Sep 30, 2026 | $547.71 |
| Aug 31, 2026 | $564.93 |
| Jul 31, 2026 | $590.73 |
| Jun 30, 2026 | $639.59 |
| May 29, 2026 | $664.05 |
| Apr 30, 2026 | $683.48 |
| Mar 31, 2026 | $650.03 |
| Feb 27, 2026 | $674.06 |
| Jan 30, 2026 | $714.51 |
| Dec 31, 2025 | $689.02 |
| Nov 28, 2025 | $628.93 |
| Oct 31, 2025 | $621.44 |
Key statistics
- Market cap
- $1.36B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $83.77K
- Net income (TTM)
- −$9.20M
- Shares outstanding
- 2.5M
- Dividend yield
- —
- 52-week range
- $531.48 – $720.03
Aclarion's market cap is $1.36B, based on a share price of $551.07 and 2.5M shares outstanding as of Jun 30, 2026.
Financials
Aclarion reported revenue of $75.73K for fiscal 2025, up 65.62% from fiscal 2024.
Aclarion reported a net loss of $7.23M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 5 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $75.73K | +65.6% | −$7.23M | −9,551.9% | −$13.61 | −$7.19M |
| FY2024ended Dec 31, 2024 | $45.72K | −39.4% | −$6.99M | −15,293.8% | −$7,478.90 | −$5.28M |
| FY2023ended Dec 31, 2023 | $75.40K | +24.8% | −$4.91M | −6,513.4% | −$79,782.00 | −$3.65M |
| FY2022ended Dec 31, 2022 | $60.44K | +0.3% | −$7.07M | −11,694.5% | −$19.61 | — |
| FY2021ended Dec 31, 2021 | $60.29K | — | −$4.95M | −8,210.5% | −$6.58 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $25.21K | −$2.75M | −$1.12 |
| Q1 FY2026ended Mar 31, 2026 | $21.14K | −$2.85M | −$1.34 |
| Q4 FY2025ended Dec 31, 2025 | $18.48K | −$1.89M | — |
| Q3 FY2025ended Sep 30, 2025 | $18.94K | −$1.71M | −$2.93 |
| Q2 FY2025ended Jun 30, 2025 | $19.32K | −$1.60M | −$2.75 |
| Q1 FY2025ended Mar 31, 2025 | $18.99K | −$2.04M | −$9.32 |
| Q4 FY2024ended Dec 31, 2024 | $10.23K | −$1.99M | — |
| Q3 FY2024ended Sep 30, 2024 | $14.41K | −$1.37M | −$1,321.49 |
Company profile
- Name
- Aclarion, Inc.
- Ticker
- ACON
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Medical Laboratories
- Headquarters
- 8181 Arista Place, Ste 100, Broomfield, CO 80021
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001635077
Recent SEC filings
- Aug 6, 2026
- Jun 4, 2026
- May 13, 2026
- Apr 22, 2026
- Mar 19, 2026
- Mar 18, 2026
- Jan 13, 2026
- Jan 9, 2026
Frequently asked questions
What is Aclarion's stock price?
Aclarion (ACON) closed at $551.07 on Oct 9, 2026, down 0.24% from the previous close of $552.39.
What is Aclarion's market cap?
Aclarion's market cap is $1.36B, based on a share price of $551.07 and 2.5M shares outstanding as of Jun 30, 2026.
How much revenue does Aclarion make?
Aclarion reported revenue of $75.73K for fiscal 2025, up 65.62% from fiscal 2024.
Does Aclarion pay a dividend?
Aclarion's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Aclarion, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures